Chemotherapy Appointment Scheduling

Serhat Gul, Ph.D., is an Associate Professor in the Department of Industrial University at TED University.  He completed his Ph.D. and M.Sc. in Industrial Engineering at Arizona State University in 2010 and 2007, respectively, and earned his B.Sc. in Industrial Engineering from Sabancı University in 2006. He has been a faculty member at TED University in Ankara, Turkey, since 2014. In 2023-2024, he served as a visiting assistant professor at the Isenberg School of Management, University of Massachusetts Amherst. Dr. Gül's primary research interests lie in stochastic optimization and its applications to healthcare delivery systems.Özlem Karsu, Ph.D., is an Associate Professor in the Department of Industrial Engineering at Bilkent University and a visiting scholar at the Technical University of Munich for the 2025–2026 academic year. She received her B.S and M.S. degrees from the Industrial Engineering Department of the Middle East Technical University, in 2008 and 2010, respectively. She received her Ph.D. degree in Operational Research from the London School of Economics in 2014.  Dr. Karsu’s research lies in the domains of inequity-averse optimization and multicriteria decision making. She aims to help decision makers to address equity (fairness) concerns through operations research tools.

• Introduction: Background Information on Chemotherapy Delivery.- Chemotherapy Scheduling.- Uncertainty in Chemotherapy Scheduling.- Fairness in Chemotherapy Scheduling.- Case Study.- Conclusion and Future Directions.